|
|
Volumn 70, Issue 4 S, 1992, Pages 1775-1781
|
|
Prognosis and treatment decisions in patients with breast cancer without axillary node involvement
|
|
Author keywords
breast cancer; estrogen receptor; flow cytometry; nuclear grade; oncogenes; prognostic factors; treatment; tumor size
|
|
Indexed keywords
CATHEPSIN D;
CYCLOPHOSPHAMIDE;
DNA;
ESTROGEN;
ESTROGEN RECEPTOR;
FLUOROURACIL;
METHOTREXATE;
PREDNISONE;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
AXILLARY LYMPH NODE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER GRADING;
CANCER RECURRENCE;
CANCER SURVIVAL;
CONFERENCE PAPER;
DNA SYNTHESIS;
ENDOMETRIUM CARCINOMA;
FEMALE;
FLOW CYTOMETRY;
GENE AMPLIFICATION;
HIGH RISK POPULATION;
HUMAN;
MEDICAL DECISION MAKING;
ONCOGENE;
PLOIDY;
PRIORITY JOURNAL;
PROGNOSIS;
THROMBOPHLEBITIS;
TUMOR VOLUME;
AXILLA;
BREAST NEOPLASMS;
CATHEPSIN D;
CELL DIVISION;
CELL NUCLEUS;
DECISION MAKING;
FEMALE;
HUMAN;
LYMPH NODES;
MODELS, STATISTICAL;
MULTIVARIATE ANALYSIS;
NEOPLASM RECURRENCE, LOCAL;
ONCOGENE PROTEINS, VIRAL;
PLOIDIES;
PROGNOSIS;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
SUPPORT, U.S. GOV'T, P.H.S.;
SURVIVAL ANALYSIS;
|
|
EID: 0026756412
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19920915)70:4+<1775::AID-CNCR2820701619>3.0.CO;2-8 Document Type: Article |
|
Times cited : (41)
|
|
References (17)
|
